Skip to Main content Skip to Navigation
Journal articles

A methodological framework for drug development in rare diseases

Abstract : Developing orphan drugs is challenging because of their severity and the requisite for effectivedrugs. The small number of patients does not allow conducting adequately powered randomized controlled trials(RCTs). There is a need to develop high quality, ethically investigated, and appropriately authorized medicines,without subjecting patients to unnecessary trials.
Document type :
Journal articles
Complete list of metadata
Contributor : Vitaly Volpert <>
Submitted on : Friday, December 19, 2014 - 10:48:12 AM
Last modification on : Tuesday, July 20, 2021 - 5:20:07 PM

Links full text



Patrice Nony, Polina Kurbatova, Agathe Bajard, Salma Malik, Charlotte Castellan, et al.. A methodological framework for drug development in rare diseases. Orphanet Journal of Rare Diseases, BioMed Central, 2014, 9 (164), pp.1-10. ⟨10.1186/s13023-014-0164-y⟩. ⟨hal-01097224⟩



Record views